235 related articles for article (PubMed ID: 35965293)
1. New insights in osteoarthritis diagnosis and treatment: Nano-strategies for an improved disease management.
Paesa M; Alejo T; Garcia-Alvarez F; Arruebo M; Mendoza G
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1844. PubMed ID: 35965293
[TBL] [Abstract][Full Text] [Related]
2. Management of osteoarthritis: From drug molecules to nano/micromedicines.
Di Francesco M; Fragassi A; Pannuzzo M; Ferreira M; Brahmachari S; Decuzzi P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1780. PubMed ID: 35253405
[TBL] [Abstract][Full Text] [Related]
3. Biomaterial strategies for improved intra-articular drug delivery.
Mancipe Castro LM; García AJ; Guldberg RE
J Biomed Mater Res A; 2021 Apr; 109(4):426-436. PubMed ID: 32780515
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities.
Mohammadinejad R; Ashrafizadeh M; Pardakhty A; Uzieliene I; Denkovskij J; Bernotiene E; Janssen L; Lorite GS; Saarakkala S; Mobasheri A
Curr Rheumatol Rep; 2020 Apr; 22(4):12. PubMed ID: 32248371
[TBL] [Abstract][Full Text] [Related]
5. Targeting macrophage polarization as a promising therapeutic strategy for the treatment of osteoarthritis.
Wang W; Chu Y; Zhang P; Liang Z; Fan Z; Guo X; Zhou G; Ren W
Int Immunopharmacol; 2023 Mar; 116():109790. PubMed ID: 36736223
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology and Osteoarthritis. Part 2: Opportunities for advanced devices and therapeutics.
Lawson TB; Mäkelä JTA; Klein T; Snyder BD; Grinstaff MW
J Orthop Res; 2021 Mar; 39(3):473-484. PubMed ID: 32860444
[TBL] [Abstract][Full Text] [Related]
7. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
8. New molecular targets for the treatment of osteoarthritis.
Alcaraz MJ; Megías J; García-Arnandis I; Clérigues V; Guillén MI
Biochem Pharmacol; 2010 Jul; 80(1):13-21. PubMed ID: 20206140
[TBL] [Abstract][Full Text] [Related]
9. Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease?
van den Bosch MHJ
Clin Exp Immunol; 2019 Feb; 195(2):153-166. PubMed ID: 30421798
[TBL] [Abstract][Full Text] [Related]
10. Osteoarthritis: pathogenic signaling pathways and therapeutic targets.
Yao Q; Wu X; Tao C; Gong W; Chen M; Qu M; Zhong Y; He T; Chen S; Xiao G
Signal Transduct Target Ther; 2023 Feb; 8(1):56. PubMed ID: 36737426
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine and regenerative medicine approaches in osteoarthritis therapy.
Goudarzi R; Dehpour AR; Partoazar A
Aging Clin Exp Res; 2022 Oct; 34(10):2305-2315. PubMed ID: 35867240
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
Abadie E; Ethgen D; Avouac B; Bouvenot G; Branco J; Bruyere O; Calvo G; Devogelaer JP; Dreiser RL; Herrero-Beaumont G; Kahan A; Kreutz G; Laslop A; Lemmel EM; Nuki G; Van De Putte L; Vanhaelst L; Reginster JY;
Osteoarthritis Cartilage; 2004 Apr; 12(4):263-8. PubMed ID: 15023377
[TBL] [Abstract][Full Text] [Related]
13. Current Treatment Options for Osteoarthritis.
Hermann W; Lambova S; Muller-Ladner U
Curr Rheumatol Rev; 2018; 14(2):108-116. PubMed ID: 28875826
[TBL] [Abstract][Full Text] [Related]
14. Engineering Hyaluronic Acid for the Development of New Treatment Strategies for Osteoarthritis.
Kim YS; Guilak F
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955795
[TBL] [Abstract][Full Text] [Related]
15. Non-surgical osteoarthritis therapy, intra-articular drug delivery towards clinical applications.
Liang Y; Xu X; Xu L; Prasadam I; Duan L; Xiao Y; Xia J
J Drug Target; 2021 Jul; 29(6):609-616. PubMed ID: 33356642
[TBL] [Abstract][Full Text] [Related]
16. Intra-articular targeting of nanomaterials for the treatment of osteoarthritis.
Brown S; Kumar S; Sharma B
Acta Biomater; 2019 Jul; 93():239-257. PubMed ID: 30862551
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of (osteo)arthritis.
Mobasheri A; Henrotin Y
Biomarkers; 2015; 20(8):513-8. PubMed ID: 26954784
[TBL] [Abstract][Full Text] [Related]
18. Wnt signaling: a promising target for osteoarthritis therapy.
Wang Y; Fan X; Xing L; Tian F
Cell Commun Signal; 2019 Aug; 17(1):97. PubMed ID: 31420042
[TBL] [Abstract][Full Text] [Related]
19. Potential of Phytomolecules in Alliance with Nanotechnology to Surmount the Limitations of Current Treatment Options in the Management of Osteoarthritis.
Mourya A; Shubhra ; Bajwa N; Baldi A; Singh KK; Pandey M; Singh SB; Madan J
Mini Rev Med Chem; 2023; 23(9):992-1032. PubMed ID: 35546778
[TBL] [Abstract][Full Text] [Related]
20. Anticytokine therapy for osteoarthritis: evidence to date.
Malemud CJ
Drugs Aging; 2010 Feb; 27(2):95-115. PubMed ID: 20104937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
